Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy

被引:26
作者
Leonardo, Costantino [1 ]
Simone, Giuseppe [2 ]
Papalia, Rocco [2 ]
Franco, Giorgio [1 ]
Guaglianone, Salvatore [2 ]
Gallucci, Michele [2 ]
机构
[1] Univ Roma La Sapienza, Dept Urol, Rome, Italy
[2] Regina Elena Inst Canc Res, Dept Urol, Rome, Italy
关键词
prostate cancer; radiation therapy; radical prostatectomy; salvage surgery; ANTIGEN; RADIOTHERAPY; OUTCOMES; MORBIDITY; SURGERY; FAILURE;
D O I
10.1111/j.1442-2042.2008.02209.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Salvage radical prostatectomy is considered for patients with locally recurrent prostate cancer after external beam radiotherapy. Between 2001 and 2004, 32 men treated with curative intent with radiotherapy for prostate cancer were subsequently treated with salvage surgery for clinically localized prostate cancer. We assessed the morbidity associated with this procedure and the outcome of the patients. Thirty-two patients underwent salvage radical prostatectomy. Initial pre-radiation median prostate-specific antigen was 13 ng/ml. Pre-radiation disease was clinical stage T1b in five cases, T2a in 10, T2b in 10 and T3a in seven. Mean operative time was 122 minutes, intraoperative blood loss was 550 ml and hospital stay and catheterization time were 5 and 12 days, respectively. There was biochemical failure in eight patients after salvage radical prostatectomy and 24 patients are biochemical non evidence of disease (bNED). In recurrent prostate local disease with prostate-specific antigen < 10 ng/ml and life expectancy greater than 10 years, salvage radical prostatectomy is a reasonable treatment option.
引用
收藏
页码:584 / 586
页数:3
相关论文
共 15 条
[1]   Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer [J].
Amling, CL ;
Lerner, SE ;
Martin, SK ;
Slezak, JM ;
Blute, ML ;
Zincke, H .
JOURNAL OF UROLOGY, 1999, 161 (03) :857-862
[2]   Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: Data from cancer of the prostate strategic urologic research endeavor [J].
Grossfeld, GD ;
Li, YP ;
Lubeck, DP ;
Broering, JM ;
Mehta, SS ;
Carroll, PR .
JOURNAL OF UROLOGY, 2002, 168 (02) :530-535
[3]   THE FREQUENCY AND MORBIDITY OF LOCAL TUMOR RECURRENCE AFTER DEFINITIVE RADIOTHERAPY FOR STAGE-C PROSTATE-CANCER [J].
HOLZMAN, M ;
CARLTON, CE ;
SCARDINO, PT .
JOURNAL OF UROLOGY, 1991, 146 (06) :1578-1582
[4]   Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era [J].
Kuban, DA ;
Thames, HD ;
Levy, LB ;
Horwitz, EM ;
Kupelian, PA ;
Martinez, AA ;
Michalski, JM ;
Pisansky, TM ;
Sandler, HM ;
Shipley, WU ;
Zelefsky, MJ ;
Zietman, AL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (04) :915-928
[5]   Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations [J].
Lee, WR ;
Hanks, GE ;
Hanlon, A .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :230-238
[6]  
Leibovich Bradley C., 2001, Journal of Urology, V165, P389
[7]   CRITICAL-EVALUATION OF SALVAGE SURGERY FOR RADIO-RECURRENT RESISTANT PROSTATE-CANCER [J].
LERNER, SE ;
BLUTE, ML ;
ZINCKE, H .
JOURNAL OF UROLOGY, 1995, 154 (03) :1103-1109
[8]  
Rigaud J, 2002, PROG UROL, V12, P1179
[9]   SALVAGE RADICAL PROSTATECTOMY - OUTCOME MEASURED BY SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS [J].
ROGERS, E ;
OHORI, M ;
KASSABIAN, VS ;
WHEELER, TM ;
SCARDINO, PT .
JOURNAL OF UROLOGY, 1995, 153 (01) :104-110
[10]   Salvage radical prostatectomy: Quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer [J].
Sanderson, Kristin M. ;
Penson, David F. ;
Cai, Jie ;
Groshen, Susan ;
Stein, John P. ;
Lieskovsky, Gary ;
Skinner, Donald G. .
JOURNAL OF UROLOGY, 2006, 176 (05) :2025-2031